The Trading Window for Sun Pharma Advanced Research Company will close from January 1, 2025, until 48 hours post the board meeting for announcing the financial results for the quarter and nine months ended December 31, 2024. This closure aligns with the company’s insider trading policies, impacting designated persons and their immediate relatives.
Investors should consider this development as a signal of upcoming financial disclosures, which could lead to changes in sentiment depending on the performance results. There is a potential risk if results do not meet market expectations, while favorable results could enhance confidence.
All announcements from Sun Pharma Advanced Research Company Limited